title: When lymphoma and heart failure cross paths.
authors.forename: Kana
authors.initials: K
authors.lastname: Nomiyama
authors.forename: Tsunefumi
authors.initials: T
authors.lastname: Shibuya
authors.forename: Chu
authors.initials: C
authors.lastname: Kataoka
authors.forename: Yoshiyasu
authors.initials: Y
authors.lastname: Aoki
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004452:Echocardiography; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006338:Heart Neoplasms / Q000150:complications*; D006801:Humans; D008223:Lymphoma / Q000150:complications*; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D011241:Prednisone